CDK6 and glioblastoma: Furthermore, Wharton’s jelly-derived MSC (WJ-MSC)-derived exosomes transfected with miR-124 have been confirmed to sensitise GBM cells to TMZ and inhibit GBM cell proliferation and migration by directly targeting CDK6 in vitro (123).